Four things to know:
1. The company saw total revenue of $90 million, according to a news release.
2. Alphatec saw a 32 percent increase in surgical volume and 22 percent incrase in users compared to the same time last year.
3. The company is on track to hit $340 million in revenue for the fiscal year, including 40 percent full-year growth.
4. Highlights of the third quarter include the launch of Alphatec’s first expandable interbody. Alphatec also enhanced its the lateral transpsoas procedure and developed a Midline ALIF approach.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
